Targeting of the B-lineage leukemia stem cells and their progeny with norcantharidin encapsulated liposomes modified with a novel CD19 monoclonal antibody 2E8 in vitro

References

• Allen TM. (2002). Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer, 2, 750–763.
   PubMed Web of Science ®Google Scholar
• Allen TM, Mumbengegwi DR, Charrois GJ. (2005). Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates. Clin Cancer Res, 11, 3567–3573.
   PubMed Web of Science ®Google Scholar
• Bermejo-Rodríguez C, Pérez-Caro M, Pérez-Mancera PA, Sánchez-Beato M, Piris MA, Sánchez-García I. (2006). Mouse cDNA microarray analysis uncovers Slug targets in mouse embryonic fibroblasts. Genomics, 87, 113–118.
   Google Scholar
• Blair A, Sutherland HJ. (2000). Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Exp Hematol, 28, 660–671.
   PubMed Web of Science ®Google Scholar
• Cheng WW, Allen TM. (2008). Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab’ fragments and single chain Fv. J Control Release, 126, 50–58.
   PubMed Web of Science ®Google Scholar
• Chung KY, Morrone G, Schuringa JJ, Wong B, Dorn DC, Moore MA. (2005). Enforced expression of an Flt3 internal tandem duplication in human CD34+ cells confers properties of self-renewal and enhanced erythropoiesis. Blood, 105, 77–84.
   PubMedGoogle Scholar
• Crosasso P, Ceruti M, Brusa P, Arpicco S, Dosio F, Cattel L. (2000). Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release, 63, 19–30.
   PubMed Web of Science ®Google Scholar
• Lopes de Menezes DE, Pilarski LM, Belch AR, Allen TM. (2000). Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo. Biochim Biophys Acta, 1466, 205–220.
   PubMed Web of Science ®Google Scholar
• Dorn DC, Kou CA, Png KJ, Moore MA. (2009). The effect of cantharidins on leukemic stem cells. Int J Cancer, 124, 2186–2199.
   PubMed Web of Science ®Google Scholar
• Harata M, Soda Y, Tani K, et al. (2004). CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells. Blood, 104, 1442–1449.
   PubMed Web of Science ®Google Scholar
• Iden DL, Allen TM. (2001). In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochim Biophys Acta, 1513, 207–216.
   PubMed Web of Science ®Google Scholar
• Immordino ML, Brusa P, Arpicco S, Stella B, Dosio F, Cattel L. (2003). Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J Control Release, 91, 417–429.
   PubMed Web of Science ®Google Scholar
• Inukai T, Inoue A, Kurosawa H, et al. (1999). SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Mol Cell, 4, 343–352.
   PubMedGoogle Scholar
• Jordan CT, Upchurch D, Szilvassy SJ, et al. (2000). The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia, 14, 1777–1784.
   PubMed Web of Science ®Google Scholar
• Köhler G, Milstein C. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 256, 495–497.
   PubMed Web of Science ®Google Scholar
• Kong Y, Yoshida S, Saito Y, et al. (2008). CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia, 22, 1207–1213.
   PubMed Web of Science ®Google Scholar
• Laginha K, Mumbengegwi D, Allen T. (2005). Liposomes targeted via two different antibodies: assay, B-cell binding and cytotoxicity. Biochim Biophys Acta, 1711, 25–32.
   PubMed Web of Science ®Google Scholar
• Li LX, Tang YM, Zhang HZ, Shen HQ, Qian BQ, Luo CF. (2008). [Preparation of the immunotoxin 2E8-norcantharidin and its targeting killing effect in vitro]. Zhonghua Er Ke Za Zhi, 46, 493–497.
   PubMedGoogle Scholar
• Park JW, Hong K, Kirpotin DB, et al. (2002). Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin Cancer Res, 8, 1172–1181.
   PubMed Web of Science ®Google Scholar
• Pastorino F, Brignole C, Marimpietri D, et al. (2003). Doxorubicin-loaded Fab’ fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice. Cancer Res, 63, 86–92.
   PubMed Web of Science ®Google Scholar
• Sapra P, Allen TM. (2002). Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs. Cancer Res, 62, 7190–7194.
   PubMed Web of Science ®Google Scholar
• Sapra P, Allen TM. (2004). Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes. Clin Cancer Res, 10, 2530–2537.
   PubMed Web of Science ®Google Scholar
• Sapra P, Moase EH, Ma J, Allen TM. (2004). Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab’ fragments. Clin Cancer Res, 10, 1100–1111.
   PubMed Web of Science ®Google Scholar
• Shojaei F, Trowbridge J, Gallacher L, et al. (2005). Hierarchical and ontogenic positions serve to define the molecular basis of human hematopoietic stem cell behavior. Dev Cell, 8, 651–663.
   PubMed Web of Science ®Google Scholar
• Sugano M, Egilmez NK, Yokota SJ, et al. (2000). Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice. Cancer Res, 60, 6942–6949.
   PubMed Web of Science ®Google Scholar
• Uckun FM, Jaszcz W, Ambrus JL, et al. (1988). Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins. Blood, 71, 13–29.
   PubMed Web of Science ®Google Scholar
• Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. (1994). Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res, 54, 4952–4957.
   PubMed Web of Science ®Google Scholar
• Yang T, Choi MK, Cui FD, Kim JS, Chung SJ, Shim CK, Kim DD. (2007). Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J Control Release, 120, 169–177.
   PubMed Web of Science ®Google Scholar
• Zhang J, Tang Y, Shen H, Qian B. (2009). Targeting and internalization of sterically stabilized liposome modified with ZCH-4-2E8. J Huazhong Univ Sci Technol Med Sci, 29, 273–280.
   PubMed Web of Science ®Google Scholar